Mammography

False-positive screening mammograms with recommendations for further evaluation could be a predictor for future breast cancers.

CHICAGO-Challenging breast density as a strong risk factor for cancer.

CHICAGO-The effect of expanded Medicaid to allow screening access on rates of breast cancer screening.

Screening mammography finds more high-grade DCIS among older women.

Radiologists reading CT colonography may see difficult-to-detect polyps but not consciously register them.

Mammography alone is just as good as mammography with CAD, and less expensive, for detecting breast cancer.

Unenhanced diagnostic MR imaging–DWIBS mammography may detect false-positive X-ray screening mammograms.

Barco’s Coronis Uniti display system received expanded clearance for multi-modality viewing.

Biennial screening mammography may detect more advanced cancers among premenopausal women than annual screening would.

Annual screening mammography can wait until age 45 for women at average risk of breast cancer.

Ultrasound and digital breast tomosynthesis find more cancers than just 2D mammography.

Adding molecular breast imaging to mammography does add to screening cost, but it also increases cancer detection.

49-year-old patient presented for bilateral screening mammogram as well as bilateral screening ultrasound due to dense breast tissue.

50-year-old male presents with palpable lump on the left breast.

Despite increase in referrals for mammography screening for high-risk women, actual screening numbers did not increase significantly.

A look at what radiologist and patient factors play a role in false-positive mammography.

FDG PET/CT scanning before treatment for invasive ductal carcinoma of the breast can predict survival.

Mammography screening detects small cancers without affecting large breast cancer detection rate or mortality from breast cancer.

Breast imaging, specifically mammography and ultrasound, are at highest risk for medicolegal claims.

Inappropriate imaging is still performed among asymptomatic women with stage I or II breast cancer in Ontario.

Clinicians were more likely to discuss breast cancer screening issues with patients following an educational intervention.

US women experience higher false-positive mammography rates than do European women.

Breast cancer screening for women aged 50 to 74 does reduce breast cancer mortality.

Case History: 55-year-old female with left breast, upper, central lump.

Case History: 67-year-old female with progressive increase in size of left breast for five years.